Managed Access Programs for LDK378, Ceritinib

NCT05100134 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Anaplastic Lymphoma Kinase (ALK)- Positive Tumors
Non-small Cell Lung Cancer (NSCLC)

Interventions

DRUG: ceritinib

Sponsor

Novartis Pharmaceuticals